Kala Pharmaceuticals, Inc. Soared
Fri, Mar 03, 2023 at 07:09 PM
Kala Pharmaceuticals, Inc. (KALA:NASDAQ) rocketted at $16.75, a gain of 64.7%. On Fri, Mar 03, 2023, KALA:NASDAQ hit a New 2-Week High of $16.75. The stock got featured on our News Catalysts scanner on Fri, Mar 03, 2023 at 09:34 AM in the 'INVESTOR UPDATE' category. From Fri, Feb 17, 2023, the stock recorded 33.33% Up Days and 50.00% Green Days
The stock spiked on Wed, Jan 04, 2023 at $56.72 with a volume of 14M+.
About Kala Pharmaceuticals, Inc. (KALA:NASDAQ)
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.
Top 10 Gainers:
- ObsEva SA (OBSV:NASDAQ), 116.98%
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 64.7%
- Genius Group Limited (GNS:NYSEMKT), 59.21%
- Etao International Co. Ltd. (ETAO:NASDAQ), 48.2%
- Creatd Inc. (CRTD:NASDAQ), 42.59%
- Decarbonization Plus Acquisition Corporation IV (DCRD:NASDAQ), 40.52%
- WaveDancer Inc. (WAVD:NASDAQ), 37.08%
- Heritage Insurance Holdings, Inc. (HRTG:NYSE), 33.82%
- Arlington Asset Investment Corp. (AI:NYSE), 33.65%
- Hub Cyber Security Ltd. (HUBC:NASDAQ), 33.6%